Health-care marketplace Sesame on Wednesday announced a new clinical weight loss program that will help eligible consumers access compounded versions of Novo Nordisk's blockbuster obesity drug Wegovy for $249 per month.Sesame allows patients to book and pay for appointments with doctors and specialists directly through its website, so it...
President Joe Biden speaks during an event at the National Institutes of Health in Bethesda, Maryland, Dec. 14, 2023.Chris Kleponis | Bloomberg | Getty ImagesThink a friend or colleague should be getting this newsletter? Share this link with them to sign up.Good afternoon! The first round of Medicare drug price...
GLP-1 Supply Tracker from Ro. Courtesy: RoTelehealth company Ro on Wednesday launched a new tracker to help patients find a popular class of weight loss and diabetes drugs called GLP-1s amid shortages of those treatments in the U.S.The supply tracker could be a valuable tool for many Americans scrambling to...
Jonathan Raa | Nurphoto | Getty ImagesThink a friend or colleague should be getting this newsletter? Share this link with them to sign up.Hi folks! Two competing cell therapies from Bristol Myers Squibb and Johnson & Johnson both got good news from the Food and Drug Administration on Friday. But...
A UnitedHealth Group health insurance card is seen in a wallet, Oct.14, 2019.Lucy Nicholson | ReutersGood afternoon! Health insurers are feeling the squeeze as older patients head to the doctor more than expected.CVS, which owns health insurer Aetna, on Wednesday slashed its full-year profit outlook, citing the potential for higher medical...
Good afternoon! All eyes are on Novo Nordisk and Eli Lilly again as Wall Street looks for signs that they can address one of the biggest hurdles they faced last year. Neither company has enough supply to meet the insatiable demand for their weight loss and diabetes drugs. One month into 2024, the two drugmakers still haven't...
Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.Good afternoon! This is Annika Kim Constantino, and I cover the biotech and pharmaceutical industry for CNBC.com. Three names in the industry – Johnson & Johnson, Merck and Bristol Myers Squibb – face...